FindTrial
Sign In

To study the results of hormonal treatment along with chemotherapy in previously treated hormone positive metastatic breast cancer patients.

Retrospective and prospective observational study to evaluate the outcome of patients with metastatic hormone-positive breast cancer treated with a combination of chemotherapy and endocrine therapyâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039242
Enrollment
1000
Registered
2022-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Not applicable: Not applicable

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients above 18 yrs who have ER and/or PR positive and HER2 negative metastatic breast cancer and who have received a combination of chemotherapy and endocrine therapy between January 2016 and December 2020.

Exclusion criteria

Exclusion criteria: Patients who have HER2 positive tumors.

Design outcomes

Primary

MeasureTime frame
1.To analyze the overall survival (OS) of included patients 2 To analyze the progression-free survival(PFS) of included patientsTimepoint: Post 6 months and 12 months of treatment completion.—

Secondary

MeasureTime frame
To analyze the time-on-treatment of the combination of chemo and endocrine therapy for included patients 9.3.2 To assess the toxicities from the combination of chemotherapy and endocrine therapy, in included patients. 9.3.2 To analyze the best overall response (complete response plus partial response, stable response or disease progression) to combination chemotherapy and endocrine therapyTimepoint: Post 6 months and 12 months of treatment completion.—

Countries

India

Contacts

Public ContactYogesh Kembhavi

Tata Memorial Centre

sudeepgupta04@yahoo.com02224177201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026